Many hematological cancers exhibit functional deregulation of Myc through genomic amplification or translocation of the Myc gene while many solid tumors, such as colorectal and lung cancer are also reported to have aberrant function of MYC, primarily caused by genomic amplification [9, 10]. The gene discussed is MYC; the disease is hematopoietic and lymphoid cell neoplasm.